The psychedelics based medicine industry may be in its nascent stages yet but there has been considerable interest from investors already and one of the stocks from the sector you could look into today is that of Clearmind Medicine Inc (OTCMKTS:CMNDF).
On Thursday, CMNDF stock ended flat at $0.50 with 1.7k shares, compared to its average volume of 3.2k shares. The stock has moved within a range of $0.5000 – 0.5000 after opening trade at $0.50.
Clearmind Medicine’s VP of Business Development Presented at The Canadian Psychedelics Association Event
The Clearmind stock was in considerable focus yesterday following an important announcement yesterday and extended its gains over the course of the past week to as much as 21%. In this situation, it may be a good idea to take a closer look at the announcement from Clearmind. Yesterday, the company announced that psychedelic medicine expert and its Vice President of Business Development, Mark Haden, had made a presentation at the Canadian Psychedelics Association earlier on in the week.
It goes without saying that the presence of a top company executive at the event was a major development for Clearmind and it remains to be seen if it results in more focus on the stock today. The event in question was mainly attended by physicians and medical professionals. The topic that had been under discussion at the panel was ‘New Psychedelic Substances’. It may be a good move for investors to add the stock to their watch lists at this point.